These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21246754)
1. Transformation of rat intestinal epithelial cells by overexpression of Rab25 is microtubule dependent. Lapierre LA; Caldwell CM; Higginbotham JN; Avant KM; Hall J; Beauchamp RD; Goldenring JR Cytoskeleton (Hoboken); 2011 Feb; 68(2):97-111. PubMed ID: 21246754 [TBL] [Abstract][Full Text] [Related]
2. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. Nam KT; Lee HJ; Smith JJ; Lapierre LA; Kamath VP; Chen X; Aronow BJ; Yeatman TJ; Bhartur SG; Calhoun BC; Condie B; Manley NR; Beauchamp RD; Coffey RJ; Goldenring JR J Clin Invest; 2010 Mar; 120(3):840-9. PubMed ID: 20197623 [TBL] [Abstract][Full Text] [Related]
4. Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors. Joshi P; Ayyagari V; Kandel S; Modur V; Iqbal MF; Robinson K; Gao J; Rao K Biomed Res Int; 2024; 2024():8544837. PubMed ID: 38803515 [TBL] [Abstract][Full Text] [Related]
5. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta. Du J; Jiang B; Coffey RJ; Barnard J Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945 [TBL] [Abstract][Full Text] [Related]
6. Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells. Allen CE; Du J; Jiang B; Huang Q; Yakovich AJ; Barnard JA Neoplasia; 2008 Oct; 10(10):1073-82. PubMed ID: 18813357 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo. Fan Y; Xin XY; Chen BL; Ma X Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986 [TBL] [Abstract][Full Text] [Related]
9. Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Shields JM; Mehta H; Pruitt K; Der CJ Mol Cell Biol; 2002 Apr; 22(7):2304-17. PubMed ID: 11884615 [TBL] [Abstract][Full Text] [Related]
11. MRTF-A/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants. Yoshio T; Morita T; Tsujii M; Hayashi N; Sobue K Carcinogenesis; 2010 Jul; 31(7):1185-93. PubMed ID: 20338973 [TBL] [Abstract][Full Text] [Related]
12. Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. Kim MJ; Woo SJ; Yoon CH; Lee JS; An S; Choi YH; Hwang SG; Yoon G; Lee SJ J Biol Chem; 2011 Apr; 286(15):12924-32. PubMed ID: 21300795 [TBL] [Abstract][Full Text] [Related]
13. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920 [TBL] [Abstract][Full Text] [Related]
14. Rab25 as a tumour suppressor in colon carcinogenesis. Goldenring JR; Nam KT Br J Cancer; 2011 Jan; 104(1):33-6. PubMed ID: 21063400 [TBL] [Abstract][Full Text] [Related]
15. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer. Gomez-Roman N; Sahasrabudhe NM; McGregor F; Chalmers AJ; Cassidy J; Plumb J Oncotarget; 2016 Apr; 7(16):22650-64. PubMed ID: 26967059 [TBL] [Abstract][Full Text] [Related]
17. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Rak J; Mitsuhashi Y; Sheehan C; Tamir A; Viloria-Petit A; Filmus J; Mansour SJ; Ahn NG; Kerbel RS Cancer Res; 2000 Jan; 60(2):490-8. PubMed ID: 10667605 [TBL] [Abstract][Full Text] [Related]
18. Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β-catenin pathway in NSCLC. Wang J; Zhou P; Wang X; Yu Y; Zhu G; Zheng L; Xu Z; Li F; You Q; Yang Q; Zhuo W; Sun J; Chen Z Cell Prolif; 2019 May; 52(3):e12592. PubMed ID: 30848009 [TBL] [Abstract][Full Text] [Related]